We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Application and Effectiveness Analysis of Internet-based Diabetes Prevention Program

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01085682
First Posted: March 12, 2010
Last Update Posted: September 12, 2014
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Kun-Ho Yoon, The Catholic University of Korea
  Purpose
This study was conducted to test the possibility of preventing or delaying the development of type 2 diabetes in individuals with impaired glucose tolerance and elevated fasting plasma glucose concentrations by internet-based diabetes prevention program.

Condition Intervention Phase
Type 2 Diabetes Behavioral: Lifestyle counseling Behavioral: Standard care Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Application and Effectiveness Analysis of Internet-based Diabetes Prevention Program

Further study details as provided by Kun-Ho Yoon, The Catholic University of Korea:

Primary Outcome Measures:
  • Incidence of Type 2 Diabetes Mellitus [ Time Frame: one year follow up ]
    Incidence of type 2 diabetes mellitus


Enrollment: 59
Study Start Date: January 2008
Study Completion Date: November 2013
Primary Completion Date: November 2013 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: Lifestyle counseling Behavioral: Lifestyle counseling
In intervention group, counseling sessions are conducted weekly for 3 months, once per two weeks for 3 months, monthly for 18 months, and then once every two months for the remainder of the study.
Active Comparator: Standard care Behavioral: Standard care
In standard care group, counseling sessions are conducted only 6 times for 4 years

Detailed Description:
Diabetes is common and rapidly increasing, because of obesity, unhealthy eating habits, and physical inactivity in Korea. Many studies reported that lifestyle modification related in the primary prevention of diabetes in multiethnic populations. The aim of this study is to determine whether internet-based interventions in those at high risk may delay the development of type 2 diabetes mellitus, and thereby reduce the incidence of cardiovascular diseases and strokes in Korean populations. In January 2008, participant recruitment began in Chung-ju city, a rural area in Korea. The subjects with impaired glucose tolerance or elevated fasting plasma glucose concentrations were selected from initial screening and then randomized to either a control or intensive lifestyle group to carry out intervention over 4 years. The primary outcome of this study is the development of diabetes by ADA criteria. To confirm the onset of diabetes, all subjects have an OGTT at the interim 6-month and each annual visit. Also, systematic evaluation examination will be done at the same time. The proportion of subjects developing diabetes in each group and the factors relating the progression will be estimated using statistical analysis.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   30 Years to 69 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Age of 30-69 years
  • BMI ≥ 20 kg/m2
  • Impaired glucose tolerance :

    2h postprandial glucose (75 g OGTT) 140-199 mg/dl or Impaired fasting glucose : Fasting plasma glucose 110-125 mg/dl

Exclusion Criteria:

  • Diabetes at baseline
  • Cardiovascular disease, cancer requiring treatment in the past 5 years, renal disease
  • Unable to communicate with clinic staff, Pregnancy and childbearing
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01085682


Locations
Korea, Republic of
Chung-ju health care center
Chung-ju, Chungchungbook-do, Korea, Republic of
Sponsors and Collaborators
The Catholic University of Korea
Investigators
Study Director: Kun-Ho Yoon, M.D., Ph.D. Kangnam St.Mary's hospital
  More Information

Responsible Party: Kun-Ho Yoon, Professor, Medical doctor, The Catholic University of Korea
ClinicalTrials.gov Identifier: NCT01085682     History of Changes
Other Study ID Numbers: KCMC07OT255
First Submitted: February 19, 2010
First Posted: March 12, 2010
Results First Submitted: September 8, 2014
Results First Posted: September 12, 2014
Last Update Posted: September 12, 2014
Last Verified: September 2014

Keywords provided by Kun-Ho Yoon, The Catholic University of Korea:
Diabetes prevention
Lifestyle modification
Obesity
Impaired glucose tolerance
Diet
Physical activity

Additional relevant MeSH terms:
Diabetes Mellitus
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases


To Top